Julian Adams
2013
In 2013, Julian Adams earned a total compensation of $2.7M as President of R&D at Infinity Pharmaceuticals, a 114% increase compared to previous year.
Compensation breakdown
Option Awards | $2,183,700 |
---|---|
Salary | $465,800 |
Other | $1,806 |
Total | $2,651,306 |
Adams received $2.2M in option awards, accounting for 82% of the total pay in 2013.
Adams also received $465.8K in salary and $1.8K in other compensation.
Rankings
In 2013, Julian Adams' compensation ranked 2,926th out of 12,286 executives tracked by ExecPay. In other words, Adams earned more than 76.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,926 out of 12,286 | 76th |
Division Manufacturing | 970 out of 4,612 | 79th |
Major group Chemicals And Allied Products | 254 out of 1,462 | 83rd |
Industry group Drugs | 172 out of 1,156 | 85th |
Industry Pharmaceutical Preparations | 142 out of 890 | 84th |
Source: SEC filing on April 25, 2016.
Adams' colleagues
We found four more compensation records of executives who worked with Julian Adams at Infinity Pharmaceuticals in 2013.